325 related articles for article (PubMed ID: 25695618)
1. TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.
Chittani M; Zaninello R; Lanzani C; Frau F; Ortu MF; Salvi E; Fresu G; Citterio L; Braga D; Piras DA; Carpini SD; Velayutham D; Simonini M; Argiolas G; Pozzoli S; Troffa C; Glorioso V; Kontula KK; Hiltunen TP; Donner KM; Turner ST; Boerwinkle E; Chapman AB; Padmanabhan S; Dominiczak AF; Melander O; Johnson JA; Cooper-Dehoff RM; Gong Y; Rivera NV; Condorelli G; Trimarco B; Manunta P; Cusi D; Glorioso N; Barlassina C
J Hypertens; 2015 Jun; 33(6):1301-9. PubMed ID: 25695618
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
Shahin MH; Sá AC; Webb A; Gong Y; Langaee T; McDonough CW; Riva A; Beitleshees AL; Chapman AB; Gums JG; Turner ST; Boerwinkle E; Scherer SE; Sadee W; Cooper-DeHoff RM; Johnson JA
Circ Cardiovasc Genet; 2017 Jan; 10(1):. PubMed ID: 28115488
[TBL] [Abstract][Full Text] [Related]
3. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
Turner ST; Boerwinkle E; O'Connell JR; Bailey KR; Gong Y; Chapman AB; McDonough CW; Beitelshees AL; Schwartz GL; Gums JG; Padmanabhan S; Hiltunen TP; Citterio L; Donner KM; Hedner T; Lanzani C; Melander O; Saarela J; Ripatti S; Wahlstrand B; Manunta P; Kontula K; Dominiczak AF; Cooper-DeHoff RM; Johnson JA
Hypertension; 2013 Aug; 62(2):391-7. PubMed ID: 23753411
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure pharmacogenomics: gazing into a misty crystal ball.
Menni C
J Hypertens; 2015 Jun; 33(6):1142-3. PubMed ID: 25923729
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK
J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599
[TBL] [Abstract][Full Text] [Related]
7. A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.
Shahin MH; Gong Y; McDonough CW; Rotroff DM; Beitelshees AL; Garrett TJ; Gums JG; Motsinger-Reif A; Chapman AB; Turner ST; Boerwinkle E; Frye RF; Fiehn O; Cooper-DeHoff RM; Kaddurah-Daouk R; Johnson JA
Hypertension; 2016 Sep; 68(3):621-9. PubMed ID: 27381900
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
Chekka LMS; Tantawy M; Langaee T; Wang D; Renne R; Chapman AB; Gums JG; Boerwinkle E; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2024 Feb; 13(4):e032433. PubMed ID: 38353215
[TBL] [Abstract][Full Text] [Related]
9. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
Chung NA; Beevers DG; Lip G
Blood Press; 2004; 13(3):183-9. PubMed ID: 15223728
[TBL] [Abstract][Full Text] [Related]
10. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
Gong Y; McDonough CW; Wang Z; Hou W; Cooper-DeHoff RM; Langaee TY; Beitelshees AL; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Turner ST; Johnson JA
Circ Cardiovasc Genet; 2012 Dec; 5(6):686-91. PubMed ID: 23087401
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
[TBL] [Abstract][Full Text] [Related]
12. Hypertension subtypes modify metabolic response to thiazide diuretics.
Huang CC; Leu HB; Huang PH; Lin LY; Wu TC; Lin SJ; Chen JW
Eur J Clin Invest; 2016 Jan; 46(1):80-91. PubMed ID: 26584406
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antihypertensive and metabolic effects of losartan and losartan in combination with hydrochlorothiazide--a randomized controlled trial.
Owens P; Kelly L; Nallen R; Ryan D; Fitzgerald D; O'Brien E
J Hypertens; 2000 Mar; 18(3):339-45. PubMed ID: 10726721
[TBL] [Abstract][Full Text] [Related]
14. Effects of losartan/diuretic combination treatment on serum uric acid levels in hypertensive patients.
Milionis HJ; Nikas S; Elisaf MS
Am J Cardiol; 2001 Nov; 88(9):1084. PubMed ID: 11704020
[No Abstract] [Full Text] [Related]
15. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.
Frau F; Zaninello R; Salvi E; Ortu MF; Braga D; Velayutham D; Argiolas G; Fresu G; Troffa C; Bulla E; Bulla P; Pitzoi S; Piras DA; Glorioso V; Chittani M; Bernini G; Bardini M; Fallo F; Malatino L; Stancanelli B; Regolisti G; Ferri C; Desideri G; Scioli GA; Galletti F; Sciacqua A; Perticone F; Degli Esposti E; Sturani A; Semplicini A; Veglio F; Mulatero P; Williams TA; Lanzani C; Hiltunen TP; Kontula K; Boerwinkle E; Turner ST; Manunta P; Barlassina C; Cusi D; Glorioso N
Pharmacogenomics; 2014 Sep; 15(13):1643-52. PubMed ID: 25410890
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications.
Neutel JM; Klein C; Meinicke TW; Schumacher H
Blood Press; 2002; 11(5):302-9. PubMed ID: 12458653
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
19. Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial.
Watanabe LA; Wei M; Sun N; Kim D; Chiang CE; Ke Y; Tseng CD; Coloma R; Vala M; Massaad R; Feig P; Guptha S
Curr Med Res Opin; 2006 Oct; 22(10):1955-64. PubMed ID: 17022855
[TBL] [Abstract][Full Text] [Related]
20. Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide.
Turner ST; Chapman AB; Schwartz GL; Boerwinkle E
Am J Hypertens; 2003 Oct; 16(10):834-9. PubMed ID: 14553962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
